<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02562170</url>
  </required_header>
  <id_info>
    <org_study_id>1401/2013</org_study_id>
    <nct_id>NCT02562170</nct_id>
  </id_info>
  <brief_title>Protexa速 Versus TiLoopBra速 in Immediate Breast Reconstruction- A Pilot Study</brief_title>
  <official_title>Protexa速 Versus TiLoopBra速 in Immediate Breast Reconstruction- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial to look at early complications, cosmetic outcome, patient
      satisfaction and thickness of the tissue overlying the implant at the lower pole in immediate
      implant based breast reconstruction after Skin or Nipple Sparing Mastectomy with either a
      mesh (TiLOOP Bra) or an ADM (Protexa). Multicenter austrian trial with four breast cancer
      centers, 50 patients randomized 1:1 in the TiLoop or Protexa group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>up to two weeks after surgery</time_frame>
    <description>hematoma, seroma, infection, skin necrosis, capsular contracture, implant loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of baseline patient quality of life after 3 and 6 months</measure>
    <time_frame>up to two weeks after surgery (=baseline), 3 and 6 months after surgery</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of baseline cosmetic outcome after 3 and 6 months</measure>
    <time_frame>up to two weeks after surgery (=baseline), 3 and 6 months after surgery</time_frame>
    <description>four point Harris Scale (1=poor, 4=excellent)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of baseline thickness of the tissue overlying the implant at the lower pole after 3 and 6 months</measure>
    <time_frame>up to two weeks after surgery (=baseline), 3 and 6 months after surgery</time_frame>
    <description>The thickness of the tissue covering the implant in the lower pole im mm measured by ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>hematoma, seroma, infection, skin necrosis, capsular contracture, implant loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>hematoma, seroma, infection, skin necrosis, capsular contracture, implant loss</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Hereditary Breast and Ovarian Cancer Syndrome</condition>
  <arm_group>
    <arm_group_label>TiLoop Bra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>immediate breast reconstruction with an implant and TiLoop Bra</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protexa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>immediate breast reconstruction with an implant and Protexa</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TiLoop Bra</intervention_name>
    <arm_group_label>TiLoop Bra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Protexa</intervention_name>
    <arm_group_label>Protexa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast cancer patients with indication for skin or nipple sparing mastectomy

          -  BRCA1/2 mutation carriers with indication for skin or nipple sparing mastectomy

        Exclusion Criteria:

          -  prior local radiotherapy

          -  inflammatory breast cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daphne Gschwantler-Kaulich, Ass.Prof.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2015</study_first_submitted>
  <study_first_submitted_qc>September 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2015</study_first_posted>
  <last_update_submitted>September 26, 2015</last_update_submitted>
  <last_update_submitted_qc>September 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Daphne Gschwantler-Kaulich</investigator_full_name>
    <investigator_title>Ass.Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>breast</keyword>
  <keyword>reconstruction</keyword>
  <keyword>mesh</keyword>
  <keyword>acellular dermal matrix</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hereditary Breast and Ovarian Cancer Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

